IDH1 and central nervous system cancer: Although a decrease in glutathione levels increases exposure to free radicals and reactive oxygen species, it has been suggested that the cellular depletion of glutathione contributes to the increased sensitivity to adjuvant radiotherapy in IDH mutated gliomas [21].